1. Home
  2. MKSI vs ROIV Comparison

MKSI vs ROIV Comparison

Compare MKSI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKSI
  • ROIV
  • Stock Information
  • Founded
  • MKSI 1961
  • ROIV 2014
  • Country
  • MKSI United States
  • ROIV United Kingdom
  • Employees
  • MKSI N/A
  • ROIV N/A
  • Industry
  • MKSI Industrial Machinery/Components
  • ROIV Biotechnology: Pharmaceutical Preparations
  • Sector
  • MKSI Industrials
  • ROIV Health Care
  • Exchange
  • MKSI Nasdaq
  • ROIV Nasdaq
  • Market Cap
  • MKSI 9.6B
  • ROIV 8.4B
  • IPO Year
  • MKSI 1999
  • ROIV N/A
  • Fundamental
  • Price
  • MKSI $107.85
  • ROIV $12.12
  • Analyst Decision
  • MKSI Strong Buy
  • ROIV Strong Buy
  • Analyst Count
  • MKSI 9
  • ROIV 10
  • Target Price
  • MKSI $145.89
  • ROIV $17.39
  • AVG Volume (30 Days)
  • MKSI 764.5K
  • ROIV 4.7M
  • Earning Date
  • MKSI 10-30-2024
  • ROIV 11-11-2024
  • Dividend Yield
  • MKSI 0.81%
  • ROIV N/A
  • EPS Growth
  • MKSI N/A
  • ROIV N/A
  • EPS
  • MKSI 0.12
  • ROIV 5.65
  • Revenue
  • MKSI $3,580,000,000.00
  • ROIV $158,303,000.00
  • Revenue This Year
  • MKSI N/A
  • ROIV $45.51
  • Revenue Next Year
  • MKSI $10.00
  • ROIV $37.40
  • P/E Ratio
  • MKSI $903.42
  • ROIV $2.19
  • Revenue Growth
  • MKSI N/A
  • ROIV 101.44
  • 52 Week Low
  • MKSI $63.44
  • ROIV $8.25
  • 52 Week High
  • MKSI $147.40
  • ROIV $13.24
  • Technical
  • Relative Strength Index (RSI)
  • MKSI 43.10
  • ROIV 57.21
  • Support Level
  • MKSI $104.67
  • ROIV $12.16
  • Resistance Level
  • MKSI $112.40
  • ROIV $13.06
  • Average True Range (ATR)
  • MKSI 4.35
  • ROIV 0.40
  • MACD
  • MKSI -0.35
  • ROIV 0.01
  • Stochastic Oscillator
  • MKSI 21.51
  • ROIV 39.87

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: